Advisors Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Advisors Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-16,260	Closed	-$268K	–	1832
2014 Q4	$268K	Sell	16,260 -2,795	-15%	-$48K	﹤0.01%	1252
2014 Q3	$337K	Sell	19,055 -897	-4%	-$17.6K	﹤0.01%	1144
2014 Q2	$412K	Sell	19,952 -949	-5%	-$19.5K	0.01%	1093
2014 Q1	$455K	Buy	20,901 +7,081	+51%	+$162K	0.01%	1030
2013 Q4	$367K	Buy	+13,820	New	+$340K	0.01%	1048
2013 Q3	–	Sell	-374	Closed	-$8K	–	1804
2013 Q2	$8K	Buy	+374	New	+$8.07K	﹤0.01%	1734

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Advisors Asset Management's VIVO Position: Q1 2015 in Review

Advisors Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2015, closing a stake of 16,260 shares — an estimated $268K sold.

Advisors Asset Management first reported a position in VIVO in Q2 2013 and held it in 6 quarters. The position peaked at $455K in Q1 2014. 159 funds tracked by Wall St. Rank hold VIVO as of Q1 2015.

Advisors Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2015 after selling out during the quarter.
Advisors Asset Management sold 16,260 Meridian Bioscience Inc shares in Q1 2015, an estimated $268K.
Advisors Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 6 quarters.
Advisors Asset Management's Meridian Bioscience Inc position peaked at $455K in Q1 2014.
159 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2015.

Based on Advisors Asset Management's 13F filing for Q1 2015, filed 13 May 2015.